Owlet, Inc. (OWLT) research
Owlet, Inc.- Sector
- Healthcare
- Industry
- Medical Devices
- Last price
- $5.21
- As of
Owlet, Inc. (OWLT): 3 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-08-14.
As of . Source: SEC EDGAR filings for OWLT. Method and limitations.
Share the OWLT intelligence card
See OWLT live in the terminal
Track OWLT's insider trades, 13F flows, options positioning, and cross asset confluence as they update, on one live board. Free account.
Open the live OWLT terminal, freeActive signals for OWLT
- highINSTITUTIONAL_EXIT
MILLENNIUM MANAGEMENT LLC cut 69% of OWLT (2026Q2)
- highINSTITUTIONAL_EXIT
CITADEL ADVISORS LLC cut 58% of OWLT (2026Q2)
- highINSTITUTIONAL_SURGE
CITADEL ADVISORS LLC added +509% to OWLT (2026Q2)
- highINSTITUTIONAL_EXIT
MILLENNIUM MANAGEMENT LLC cut 69% of OWLT (2026Q2)
- highINSTITUTIONAL_EXIT
CITADEL ADVISORS LLC cut 58% of OWLT (2026Q2)
FREE, NO ACCOUNT
Every signal on OWLT, as it fires
You are seeing 5 of 16 signals recorded on OWLT since 2026-05-17.
The five above all landed on 2026-09-06. The other 11 were recorded on 3 other days. 11 of the 16 are institutional flow rows, which arrive in batches on filing days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in OWLT (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| CITADEL ADVISORS LLCCUSIP 69120X206 · 2026Q2 | $1.4M | 0.00% | , |
| RENAISSANCE TECHNOLOGIES LLCCUSIP 69120X206 · 2026Q2 | $1.2M | 0.00% | , |
| MILLENNIUM MANAGEMENT LLCCUSIP 69120X206 · 2026Q2 | $378K | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, OWLT
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
OWLT against its peers
OWLT's operating margin of -7.8% ranks in the 84th percentile of 21 Medical Devices sub-industry peers, fiscal periods ending between 2025-12-31 and 2026-06-30.
| Metric | OWLT | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 106M USD | 51.7M USD | 75 | 21 |
| Gross margin | 50.6% | 60.0% | 39 | 18 |
| Operating margin | -7.8% | -59.7% | 84 | 21 |
| Net margin | -37.5% | -77.1% | 70 | 21 |
| Return on equity | -208.4% | -70.9% | 13 | 19 |
Peers (22): QTRX, LUCD, QSI, EBRCZ, APYX, ECOR, STIM, ELMD, LNSR, LUNG, INFU, HYPR, SERA, CVRX, TMCI, ZOMDF, LAB, TLSI, MYO, CATX, VMD, POSC. Left out: PROF (no annual filing), RTGN (no annual filing), MOBI (no annual filing). Fiscal periods ending between 2025-12-31 and 2026-06-30. Every figure is one full fiscal year read from one annual filing (OWLT: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
See more OWLT signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to OWLTand get the insider, 13F, options, and confluence read in one view.